(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
-3.53% $ 0.820
Live Chart Being Loaded With Signals
Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage...
Stats | |
---|---|
Volumen de hoy | 1.03M |
Volumen promedio | 22 706.00 |
Capitalización de mercado | 40.02M |
EPS | $0 ( 2024-02-23 ) |
Last Dividend | $0.0150 ( 2023-09-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 27.33 |
ATR14 | $0 (0.00%) |
Cryosite Ltd Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cryosite Ltd Finanzas
Annual | 2023 |
Ingresos: | $11.94M |
Beneficio Bruto: | $6.48M (54.28 %) |
EPS: | $0.0289 |
FY | 2023 |
Ingresos: | $11.94M |
Beneficio Bruto: | $6.48M (54.28 %) |
EPS: | $0.0289 |
FY | 2022 |
Ingresos: | $11.76M |
Beneficio Bruto: | $6.27M (53.36 %) |
EPS: | $0.0279 |
FY | 2021 |
Ingresos: | $10.02M |
Beneficio Bruto: | $5.89M (58.80 %) |
EPS: | $0.0139 |
Financial Reports:
No articles found.
Cryosite Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0100 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.0150 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00500 | 2012-03-16 |
Last Dividend | $0.0150 | 2023-09-07 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | $0.0900 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.12 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.33 | |
Div. Directional Score | 8.29 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PRU.AX | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
ASG.AX | Ex Dividend Junior | 2023-10-31 | Annually | 0 | 0.00% | |
IFT.AX | Ex Dividend Knight | 2023-05-29 | Semi-Annually | 0 | 0.00% | |
SFC.AX | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
CD1.AX | Ex Dividend Junior | 2023-08-17 | Semi-Annually | 0 | 0.00% | |
MEZ.AX | Ex Dividend Knight | 2023-09-06 | Semi-Annually | 0 | 0.00% | |
TOP.AX | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
CWP.AX | Ex Dividend Junior | 2023-09-27 | Semi-Annually | 0 | 0.00% | |
NSR.AX | Ex Dividend Knight | 2023-06-29 | Semi-Annually | 0 | 0.00% | |
FID.AX | Ex Dividend Knight | 2023-08-25 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.125 | 1.500 | 7.50 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0711 | 1.200 | 7.63 | 9.16 | [0 - 0.3] |
returnOnEquityTTM | 0.555 | 1.500 | 4.94 | 7.41 | [0.1 - 1] |
payoutRatioTTM | 0.464 | -1.000 | 5.36 | -5.36 | [0 - 1] |
currentRatioTTM | 2.03 | 0.800 | 4.85 | 3.88 | [1 - 3] |
quickRatioTTM | 1.942 | 0.800 | 3.28 | 2.63 | [0.8 - 2.5] |
cashRatioTTM | 1.458 | 1.500 | 3.01 | 4.51 | [0.2 - 2] |
debtRatioTTM | 0.114 | -1.500 | 8.10 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 15.39 | 1.000 | 5.41 | 5.41 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0493 | 2.00 | 9.98 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0405 | 2.00 | 9.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.873 | -1.500 | 6.51 | -9.76 | [0 - 2.5] |
grossProfitMarginTTM | 0.550 | 1.000 | 4.17 | 4.17 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.138 | 1.000 | 9.23 | 9.23 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.952 | 1.000 | 5.82 | 5.82 | [0.2 - 2] |
assetTurnoverTTM | 0.569 | 0.800 | 9.54 | 7.63 | [0.5 - 2] |
Total Score | 11.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 25.39 | 1.000 | 7.54 | 0 | [1 - 100] |
returnOnEquityTTM | 0.555 | 2.50 | 6.75 | 7.41 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0405 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 7.93 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0493 | 2.00 | 9.98 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.464 | 1.500 | 5.36 | -5.36 | [0 - 1] |
pegRatioTTM | -0.508 | 1.500 | -6.72 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.191 | 1.000 | 7.73 | 0 | [0.1 - 0.5] |
Total Score | 5.33 |
Cryosite Ltd
Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport, and biological storage solutions to the clinical trials, and research and pharmaceutical industry. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico